UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect

Biochemical pharmacology, 2013-05, Vol.85 (10), p.1433-1440

2013

Volltextzugriff (PDF)

Transcriptionally Driven DNA Replication Program of the Human Parasite Leishmania major

Cell reports (Cambridge), 2016-08, Vol.16 (6), p.1774-1786

2016

Volltextzugriff (PDF)

Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5264-5270

2012

Volltextzugriff (PDF)

Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis

PLoS neglected tropical diseases, 2012-11, Vol.6 (11), p.e1927-e1927

2012

Volltextzugriff (PDF)

Molecular Characterization of Tc964, A Novel Antigenic Protein from Trypanosoma cruzi

International journal of molecular sciences, 2020-03, Vol.21 (7), p.2432

2020

Volltextzugriff (PDF)

Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice

Vaccines (Basel), 2020-03, Vol.8 (1), p.141

2020

Volltextzugriff (PDF)

Proteins interacting with Leishmania major PUF1: A proteomic dataset

Data in brief, 2020-12, Vol.33, p.106594-106594, Article 106594

2020

Volltextzugriff (PDF)

Trypanosoma cruzi Ikiakarora (TcIII) Draft Genome Sequence

Microbiology resource announcements, 2020-07, Vol.9 (27)

2020

Volltextzugriff (PDF)

Extracorporeal shock wave lithotripsy for distal ureteral calculi: Improved efficacy using low frequency

International journal of urology, 2013-02, Vol.20 (2), p.214-219

2013

Volltextzugriff (PDF)

Variability of the Pr77 sequence of L1Tc retrotransposon among six T. cruzi strains belonging to different discrete typing units (DTUs)

Acta tropica, 2021-10, Vol.222, p.106053-106053, Article 106053

2021

Volltextzugriff (PDF)

Telomere-based risk models for the early diagnosis of clinically significant prostate cancer

Prostate cancer and prostatic diseases, 2021-03, Vol.24 (1), p.88-95

2021

Volltextzugriff (PDF)

Perineostomy: the last oportunity

International Brazilian journal of urology, 2015-01, Vol.41 (1), p.91-100

2015

Volltextzugriff (PDF)

Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis

Molecular immunology, 2020-11, Vol.127, p.95-106

2020

Volltextzugriff (PDF)

Rituximab, interferon‐alfa‐2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH‐PRO‐05 study

British journal of haematology, 2019-07, Vol.186 (1), p.168-170

2019

Volltextzugriff (PDF)

Vaccine candidates against leishmania under current research

Expert review of vaccines, 2018-04, Vol.17 (4), p.323-334

2018

Volltextzugriff (PDF)

Impact of the use of simulators on the mental workload and confidence in a digital rectal examination and bladder catheterization workshop.

Archivos españoles de urología, 2018-07, Vol.71 (6), p.537-542

2018

Volltextzugriff (PDF)

Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?

American journal of hematology, 2014-11, Vol.89 (11), p.E206-E211

2014

Volltextzugriff (PDF)

Draft Genome Sequence of the Trypanosoma cruzi B. M. López Strain (TcIa), Isolated from a Colombian Patient

Microbiology resource announcements, 2020-04, Vol.9 (18)

2020

Volltextzugriff (PDF)

European Randomised Study for Screening of Prostate Cancer Risk Calculator: External Validation, Variability and Clinical Significance

Urology (Ridgewood, N.J.), 2017-04, Vol.102, p.85-91

2017

Volltextzugriff (PDF)

Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

Journal of cellular and molecular medicine, 2019-02, Vol.23 (2), p.934-942

2019

Volltextzugriff (PDF)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL

BMJ open, 2019-11, Vol.9 (11), p.e031032-e031032

2019

Volltextzugriff (PDF)

Evaluation of Clinical and Biological Prognostic Factors in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients After Previous Treatment With Rituximab and Chemotherapy: Results of the PRO-R-IPI Study

Clinical lymphoma, myeloma and leukemia, 2015-07, Vol.15 (7), p.398-403

2015

Volltextzugriff (PDF)

1 – 25 von 531

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(470)
Mit Volltextzugriff
(458)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study

Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect

Transcriptionally Driven DNA Replication Program of the Human Parasite Leishmania major

Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis

Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis

Molecular Characterization of Tc964, A Novel Antigenic Protein from Trypanosoma cruzi

Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice

Proteins interacting with Leishmania major PUF1: A proteomic dataset

Trypanosoma cruzi Ikiakarora (TcIII) Draft Genome Sequence

Extracorporeal shock wave lithotripsy for distal ureteral calculi: Improved efficacy using low frequency

Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib‐treated patients with chronic myeloid leukemia with more than 10% of BCR‐ABL/ABL ratio at 3 months

Variability of the Pr77 sequence of L1Tc retrotransposon among six T. cruzi strains belonging to different discrete typing units (DTUs)

Telomere-based risk models for the early diagnosis of clinically significant prostate cancer

Perineostomy: the last oportunity

Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis

Rituximab, interferon‐alfa‐2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH‐PRO‐05 study

Vaccine candidates against leishmania under current research

Impact of the use of simulators on the mental workload and confidence in a digital rectal examination and bladder catheterization workshop.

Prospective study of diagnostic accuracy in the detection of high‐grade prostate cancer in biopsy‐naïve patients with clinical suspicion of prostate cancer who underwent the Select MDx test

Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor?

Draft Genome Sequence of the Trypanosoma cruzi B. M. López Strain (TcIa), Isolated from a Colombian Patient

European Randomised Study for Screening of Prostate Cancer Risk Calculator: External Validation, Variability and Clinical Significance

Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL

Evaluation of Clinical and Biological Prognostic Factors in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients After Previous Treatment With Rituximab and Chemotherapy: Results of the PRO-R-IPI Study

Suchergebnisse filtern